Dovitinib is an orally active small molecule that exhibits potent inhibitory activity against multiple RTKs involved in tumor growth and angiogenesis. Preclinical data show that dovitinib works to inhibit multiple kinases associated with different cancers, including acute myeloid leukemia (AML) and multiple myeloma. Chiron currently has three ongoing Phase I clinical trials for dovitinib.
Synonyms: Dovitinib
This is just here as a test because I lose it
Term information
database
cross reference
- PubChem Substance:347827750
- Wikipedia:Fibroblast_growth_factor_receptor_1
- BindingDB:25118
- PDB:38O
- ChEMBL:CHEMBL522892
- CAS:405169-16-6
- PubChem Compound:9977819
- ChemSpider:11530944
hasDbXref
CAS:405169-16-6
PubChem Compound:9977819
BindingDB:25118
ChemSpider:11530944
PubChem Substance:347827750
PDB:38O
ChEMBL:CHEMBL522892
Wikipedia:Fibroblast_growth_factor_receptor_1